What does GER stand for?

Byline: ANI Washington, Oct 25 (ANI): A new study has revealed that long-term treatment with proton pump inhibitor might make patients with gastroesophageal reflux disease (GERD) fat.

Prominent among those companies is Crospon of Galway, a medical device pioneer that just agreed to a worldwide distribution deal for its flagship gastroenterology product, EndoFLIP, a diagnostic tool for assessing the competence of the gastroesophageal junction in patients with gastroesophageal reflux disorder (GERD).

EndoFLIP, which is currently awaiting approval from the FDA, is designed to provide a more physiologically relevant diagnostic test for gastroesophageal reflux disease (GERD).

The symptoms of gastroesophageal reflux are obvious, including heart-burn and belching, complaints most apparent after meals and during the hours of sleep when an asthma patient is reclining.

Byline: pinto03 Eisai Corporation of North America, a wholly-owned subsidiary of Tokyo-based Eisai, has announced that the FDA has approved Aciphex 20mg for the short-term treatment of gastroesophageal reflux disease in adolescents ages 12 and above.

Data from recent studies show that children from 3 to 7 must endure acid reflux symptoms between 2 and 8% of the time, with this figure rising to 20% of infants who suffer Since the 1990s, infant gastroesophageal reflux disease (GERD) has been on the increase Data from recent studies show that children from 3 to 7 must endure acid reflux symptoms between 2 and 8% of the time, with this figure rising to 20% of infants who suffer.

Food and Drug Administration (FDA) has approved the use of NEXIUM[R] (esomeprazole magnesium) in children ages 1 to 11 years old for the short-term treatment of gastroesophageal reflux disease (GERD) for up to eight weeks, helping to address an important unmet need for pediatric patients.

What we know as heartburn is the most common symptom of a condition called gastroesophageal reflux or acid reflux.